| ||||||
| 111 Barclay Boulevard, Lincolnshire, IL, 60069, US. TEL: 847-478-0500 http://www.biosantepharma.com | ||||||
| Last Sale | Net Change | % Change | Volume | Last Updated | ||
|---|---|---|---|---|---|---|
| N.A. | N.A. | N.A. | N.A. | N.A. | ||
| ||||||||||||||||||||||
 |
|
||||||||||||||||||||||
| ||||
| Security Type | Common Stock | Specialist | 985 | |
| Industry | Health Services, Pharmaceuticals, and Medical Diagnostics | Trading Post | 2 | |
| Primary Exchange | Amex | 0001023024 | ||
| ||||
| Description |
|
BioSante Pharmaceuticals, Inc. develops a pipeline of hormone therapy products to treat both men and women. These hormone therapy products are gel formulations for transdermal administration that deliver bio-identical estradiol and testosterone. The company's lead products include Elestrin (estradiol gel) for the treatment of moderate-to-severe vasomotor symptoms associated with menopause; and LibiGel (transdermal testosterone gel), which is in Phase III clinical development for the treatment of female sexual dysfunction. The company's products under development include Bio-T-Gel, a testosterone gel for male hypogonadism, and an oral contraceptive in Phase II clinical development using BioSante patented technology. BioSante is also developing its calcium phosphate nanotechnology (CaP) for novel vaccines, including hepatitis B, avian flu, and biodefense vaccines for toxins, such as anthrax, as well as a system for delivering drugs via alternative routes of administration and for aesthetic medicine. Its CaP products under development comprise BioVant, a proprietary CaP adjuvant and delivery technology for vaccines against cancer, viral and bacterial infections, and autoimmune diseases; BioOral, a delivery system for oral/buccal/intranasal administration of proteins and other therapies; BioAir, a delivery system for inhalable versions of proteins and other therapies; and BioCap, which is used in the field of aesthetic medicine. The company was founded in 1996 and is headquartered in Lincolnshire, Illinois. |
| Quote |
| ||||
| Last Sale | N.A. (N.A.) | |||
| Net Change | N.A. | |||
| % Change | N.A. | |||
| Previous Close | N.A. | |||
| Today’s Open | N.A. | |||
| Today’s High | N.A. | |||
| Today’s Low | N.A. | |||
| Volume | N.A. | |||
| 52 Week High | N.A. | |||
| 52 Week Low | N.A. | |||
| ||||
| Chart |
| 3mo | 6mo | 12mo | 24mo | 36mo | 48mo | 60mo |
|
| Click here to view the data behind the chart. |
| Fundamentals |
|
||||
| P/E ratio | N.A. | Short Interest | N.A. | |
| Earnings Per Share | N.A. | Current yield | N.A. | |
| Shares Outstanding | N.A. | Dividend Info | ||
| Market Cap | N.A. | |||
|
||||
|
|
